news

The Naval Surface Warfare Center Dahlgren Division has awarded ManTech (MANT) a five-year $88 mln IDIQ task order to provide Test and Evaluation support for U.S. Navy weapons and combat systems. Pear Therapeutics (PEAR), the parent company of Pear Therapeutics (US), Inc., announces a value-based agreement with Oklahoma Health Care Authority to provide access to Pear's PDTs reSET and reSET-O to help fight the growing substance and opioid addiction crisis. Effective January 1, 2022, reSET and reSET-O will be made available to Oklahomans enrolled in Oklahoma Medicaid, commonly known as SoonerCare. Pear's products reSET and reSET-O are the first and only FDA-authorized, safe and effective PDTs for the treatment of substance use disorder and opioid use disorder, respectively. Aemetis (AMTX) announces that its subsidiary Aemetis Biogas has completed an additional seven miles of underground pipeline to transport biogas from five new dairy digesters to the centralized Renewable Natural Gas upgrading facility located at the Aemetis Keyes biofuels plant. Including the four miles of biogas pipeline commissioned in late 2020, Aemetis has now installed more than 11 miles of pipeline and is on track to complete the 36-mile biogas pipeline network in 2022. NextGen Healthcare (NXGN) announces that Lake County Tribal Health has selected NextGen Enterprise Electronic Health Records, NextGen Enterprise Practice Management and NextGen Patient Experience Platform to improve patient outcomes and optimize provider workflow. Lake County Tribal Health will also implement NextGen Behavioral Health, NextGen Therapy Suite and NextGen Virtual Visits, providing safe and convenient access to care for its 12,000 patients. Aligos Therapeutics (ALGS) announces that the first chronic hepatitis B patient has been dosed in the multiple ascending dose portion of Study ALG-020572-401 which is evaluating antisense oligonucleotide ALG-020572.